Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors January 8, 2025
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development December 16, 2024
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications December 13, 2024
New paper using Attana Technology: A broadly potent antibody targeting the different Covid-19 mutations October 9, 2024
